Take Solutions Limited - Asset Resilience Ratio
Take Solutions Limited (TAKE) has an Asset Resilience Ratio of 41.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Take Solutions Limited (TAKE) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2025)
This chart shows how Take Solutions Limited's Asset Resilience Ratio has changed over time. See debt-free asset ratio of Take Solutions Limited to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Take Solutions Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Take Solutions Limited market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs1.50 Million | 0.43% |
| Short-term Investments | Rs143.90 Million | 40.87% |
| Total Liquid Assets | Rs145.40 Million | 41.29% |
Asset Resilience Insights
- Very High Liquidity: Take Solutions Limited maintains exceptional liquid asset reserves at 41.29% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Take Solutions Limited Industry Peers by Asset Resilience Ratio
Compare Take Solutions Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND |
Biotechnology | 0.00% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE |
Biotechnology | 84.34% |
|
3SBio Inc
F:83B |
Biotechnology | 10.64% |
|
Soleno Therapeutics Inc
NASDAQ:SLNO |
Biotechnology | 20.15% |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497 |
Biotechnology | 0.02% |
|
Novavax Inc
NASDAQ:NVAX |
Biotechnology | 53.87% |
|
BB Biotech AG
SW:BION |
Biotechnology | 0.05% |
Annual Asset Resilience Ratio for Take Solutions Limited (2002–2025)
The table below shows the annual Asset Resilience Ratio data for Take Solutions Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 8.10% | Rs29.54 Million ≈ $319.46K |
Rs364.79 Million ≈ $3.95 Million |
+8.09pp |
| 2024-03-31 | 0.00% | Rs40.00K ≈ $432.58 |
Rs881.05 Million ≈ $9.53 Million |
-4.79pp |
| 2023-03-31 | 4.80% | Rs107.60 Million ≈ $1.16 Million |
Rs2.24 Billion ≈ $24.27 Million |
+2.42pp |
| 2022-03-31 | 2.38% | Rs290.71 Million ≈ $3.14 Million |
Rs12.23 Billion ≈ $132.27 Million |
+2.36pp |
| 2021-03-31 | 0.02% | Rs2.77 Million ≈ $29.96K |
Rs18.45 Billion ≈ $199.49 Million |
-0.23pp |
| 2020-03-31 | 0.25% | Rs60.99 Million ≈ $659.58K |
Rs24.83 Billion ≈ $268.55 Million |
-9.50pp |
| 2019-03-31 | 9.75% | Rs2.28 Billion ≈ $24.60 Million |
Rs23.34 Billion ≈ $252.40 Million |
-5.18pp |
| 2018-03-31 | 14.93% | Rs2.75 Billion ≈ $29.76 Million |
Rs18.44 Billion ≈ $199.38 Million |
+14.51pp |
| 2017-03-31 | 0.41% | Rs56.92 Million ≈ $615.57K |
Rs13.73 Billion ≈ $148.45 Million |
+0.28pp |
| 2016-03-31 | 0.14% | Rs16.70 Million ≈ $180.60K |
Rs12.14 Billion ≈ $131.34 Million |
-0.01pp |
| 2015-03-31 | 0.15% | Rs13.50 Million ≈ $146.00K |
Rs9.22 Billion ≈ $99.75 Million |
-5.67pp |
| 2014-03-31 | 5.81% | Rs501.50 Million ≈ $5.42 Million |
Rs8.62 Billion ≈ $93.27 Million |
-0.18pp |
| 2013-03-31 | 5.99% | Rs501.60 Million ≈ $5.42 Million |
Rs8.37 Billion ≈ $90.50 Million |
-0.78pp |
| 2012-03-31 | 6.77% | Rs501.60 Million ≈ $5.42 Million |
Rs7.41 Billion ≈ $80.10 Million |
-1.74pp |
| 2011-03-31 | 8.51% | Rs500.00 Million ≈ $5.41 Million |
Rs5.88 Billion ≈ $63.54 Million |
-3.68pp |
| 2010-03-31 | 12.19% | Rs626.01 Million ≈ $6.77 Million |
Rs5.13 Billion ≈ $55.52 Million |
+1.28pp |
| 2009-03-31 | 10.92% | Rs562.23 Million ≈ $6.08 Million |
Rs5.15 Billion ≈ $55.70 Million |
+1.67pp |
| 2008-03-31 | 9.25% | Rs367.88 Million ≈ $3.98 Million |
Rs3.98 Billion ≈ $43.03 Million |
+5.93pp |
| 2007-03-31 | 3.31% | Rs85.61 Million ≈ $925.82K |
Rs2.58 Billion ≈ $27.95 Million |
+1.20pp |
| 2006-03-31 | 2.11% | Rs19.08 Million ≈ $206.34K |
Rs905.33 Million ≈ $9.79 Million |
-4.13pp |
| 2005-03-31 | 6.24% | Rs12.16 Million ≈ $131.51K |
Rs194.89 Million ≈ $2.11 Million |
+3.44pp |
| 2004-03-31 | 2.80% | Rs3.96 Million ≈ $42.83K |
Rs141.45 Million ≈ $1.53 Million |
+2.06pp |
| 2003-03-31 | 0.74% | Rs700.00K ≈ $7.57K |
Rs94.72 Million ≈ $1.02 Million |
-0.77pp |
| 2002-03-31 | 1.51% | Rs450.00K ≈ $4.87K |
Rs29.90 Million ≈ $323.36K |
-- |
About Take Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient c… Read more